Mode
Home
Research
Clinical Trials Drug Pipeline Weekly Digests
Reference
Conditions Medications
Community
Questions
Text Size
Log in / Sign up
Home › Medications › Ziprasidone

Ziprasidone

0 published articles · Updated continuously

Clinical Trial Landscape

Clinical Trials of Ziprasidone

29 trials tracked of Ziprasidone: 18 in phase 3 or 4 and 2 with published results. The most-cited published study has 205 citations.

29Trials tracked
18Phase 3 & 4
0Recruiting
2With published results
Phase distribution
Phase 4 10 Phase 3 8 Phase 2 6 Other / NA 5
  1. Phase 3 Efficacy and Safety of Iloperidone Compared With Placebo and Active Control in Subjects With Acute Schizophrenia Completed · 205 cited
  2. Phase 4 Ziprasidone in Bipolar Disorder With Comorbid Lifetime Panic or Generalized Anxiety Disorder(GAD) Completed · 22 cited
  3. Phase 4 Ziprasidone Switching in Response to Adherence and Psychotropic-Related Weight Gain Concerns Among Patients With Bipolar Disorder (Zip Ad) Completed
  4. Phase 4 Preventing Relapse in Schizophrenia: Oral Antipsychotics Compared To Injectables: Evaluating Efficacy Completed
  5. Phase 4 Predictors of Response to Augmentation With Ziprasidone (Geodon®) in Major Depressive Disorder Completed
  6. Phase 4 Study Evaluating The Safety, Tolerability, And Efficacy Of Switching From Quetiapine To Ziprasidone Completed
Show 23 more trials
  1. Phase 4 Open-Label Study of Geodon in Non-Rapid Cycling Bipolar II Patients With Major Depression Completed
  2. Phase 4 Ziprasidone for Clozapine- or Olanzapine-Associated Diabetes Mellitus Completed
  3. Phase 4 Efficacy and Tolerability of Switching to Ziprasidone From Other Antipsychotics Completed
  4. Phase 4 Ziprasidone in Pediatric Bipolar Disorder Completed
  5. Phase 4 Switching Medication to Treat Schizophrenia Completed
  6. Phase 3 Extension Study: Evaluating the Safety of Oral Ziprasidone in the Treatment of Subjects With Schizophrenia Completed
  7. Phase 3 3-week Study to Evaluate Efficacy and Safety of Ziprasidone With Either Lithium or Divalproex in Acutely Manic Subjects Completed
  8. Phase 3 Extension Study of Patients Successfully Treated by Ziprasidone in Study A1281031 Completed
  9. Phase 3 The Modifying the Impact of ICU-Associated Neurological Dysfunction-USA (MIND-USA) Study Completed
  10. Phase 3 Open-label Ziprasidone Study for Psychosis Treatment in Adolescents Completed
  11. Phase 3 Adjunctive Ziprasidone in the Treatment of Bipolar I Depression Completed
  12. Phase 3 Ziprasidone vs. Sertraline/Haloperidol in Psychotic Depression Completed
  13. Phase 2 Geodon for the Treatment of Refractory Social Anxiety Disorder Completed
  14. Phase 2 A Study to Assess the Safety and Efficacy of ASP4345 as Add-on Treatment for Cognitive Impairment in Subjects With Schizophrenia on Stable Doses of Antipsychotic Medication Completed
  15. Phase 2 Ziprasidone in the Psychosis Prodrome Completed
  16. Phase 2 A 12-Week, Placebo Controlled Trial of Ziprasidone as Monotherapy for Major Depressive Disorder Completed
  17. Phase 2 Safety Study of Ziprasidone (Geodon) for the Depressive Mixed State Completed
  18. Phase 2 Ziprasidone Augmentation of SSRIs for Patients With Major Depressive Disorder (MDD) That do Not Sufficiently Respond to Treatment With SSRIs Completed
  19. N/A A Non-Interventional Post-Marketing Surveillance Study to Evaluate the Safety and Efficacy of Zeldox Capsule Completed
  20. N/A Glucose and Lipid Metabolism on Antipsychotic Medication Completed
  21. N/A Improving Diabetes Risk Factors in Persons With Schizophrenia or Bipolar Disorder by Switching to Ziprasidone Completed
  22. N/A Treatment of Schizophrenic Patients With Ziprasidone Completed
  23. N/A Healthy Volunteers Study of the Effects of Olanzapine and Ziprasidone Completed

Showing the 29 most-cited and recently-updated of 29 trials. Browse the full registry →

Trial data sourced from ClinicalTrials.gov. Counts describe the research landscape and are not a treatment recommendation. Informational only — not medical advice.

HCP Mode — summaries include clinical detail, trial data, and statistical outcomes.
Patient Mode — summaries use plain language, avoiding clinical jargon.
No published articles yet for this medication. Check back soon.